Biohit Oyj - Company Announcement

Biohit Oyj and Eastar Pharmaceuticals LLC to sign an Acetium® lozenge distribution agreement

Biohit Oyj Biohit Oyj Stock Exchange Release August 15, 2014 at 9:30 a.m. local
time (EEST) 


Biohit Oyj has signed a distribution agreement with Eastar Pharmaceuticals LLC.
The agreement is effective immediately and Eastar Pharmaceuticals LLC gains
exclusive rights for the distribution of Acetium® lozenge in China. 

The Acetium® lozenge is intended for smokers to bind acetaldehyde that
dissolves in saliva during smoking. Acetaldehyde is the most important
carcinogen in cigarette smoke. (1,2) 

CEO Semi Korpela, Biohit Oyj: ‘We welcome Eastar Pharmaceuticals LLC to join
our distribution network. The Acetium® lozenge Chinese registration procedures
and distribution channel preparations start now together with a strong partner.
‘ 

CEO Tony Chu, Eastar Pharmaceuticals LLC: ‘We are very excited about working
with the Biohit team. Biohit's Acetium® product reduces the health risks among
smokers and could be an integral part of Chinese consumers' daily lives.' 

On-going clinical studies with the Acetium® lozenge:
Clinical intervention trial with Acetium® lozenge aimed at smoking cessation,
read more at http://goo.gl/2vcvbt. 

References:
(1) Haussmann H-J (2012) Use of hazard indices for a theoretical evaluation of
cigarette smoke composition. Chem Res Toxicol 2012;25:794-810. 
(2) Burns DM et al (2008) Mandated lowering of toxicants in cigarette smoke: a
description of the World Health Organization TobReg proposal. Tob Control
2008;17:132-41. 


Additional information:

CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com


Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit's
mission is “Innovating for Health” - we produce innovative products and
services to promote research and early diagnosis. Biohit is headquartered in
Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B
share (BIOBV) is quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare
group. www.biohithealthcare.com 


Eastar Pharmaceuticals LLC in brief

Eastar Pharmaceuticals LLC is a US pharmaceutical investment advisory and
licensing company. With its strategic partners, subsidiaries and joint venture
companies, Eastar licenses and markets innovative pharmaceuticals, medical
devices, diagnostics and health related products to China and ASEAN countries.
www.chinaeastar.com/en/